Medi Caps Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2025 ,inter alia, to consider and approve 1.Consider and approve the Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medi Caps Limited has informed BSE that a meeting of its Board of Directors is scheduled for Wednesday, 21st May 2025 at its registered office in Indore. The main agenda is to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the fourth quarter and full financial year ended 31st March 2025, along with the auditor's report. Other routine business matters may also be taken up with the chair's permission. The company has also noted that the trading window for insiders will reopen 48 hours after the declaration of these audited results. No actual financial numbers or outcomes have been disclosed in this filing — it is purely a pre-meeting intimation as required under SEBI LODR regulations.
This is a routine regulatory intimation and does not contain any financial data or business decision. Investors should wait for the actual audited results on or after 21st May 2025 to assess the company's FY25 performance, which could influence the stock price. The closed trading window until results are declared means insider buying or selling is restricted.